vs

Side-by-side financial comparison of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) and Vitesse Energy, Inc. (VTS). Click either name above to swap in a different company.

Vitesse Energy, Inc. is the larger business by last-quarter revenue ($58.6M vs $44.6M, roughly 1.3× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). Vitesse Energy, Inc. runs the higher net margin — -1.3% vs -90.4%, a 89.2% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs 4.8%). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -2.1%).

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

Vitesse Energy, Inc. is a U.S.-headquartered independent energy company focused on exploration, development, and production of oil and natural gas assets. It operates primarily in high-potential onshore basins including North Dakota's Williston Basin, serving domestic and global upstream energy market demand.

PACB vs VTS — Head-to-Head

Bigger by revenue
VTS
VTS
1.3× larger
VTS
$58.6M
$44.6M
PACB
Growing faster (revenue YoY)
PACB
PACB
+9.0% gap
PACB
13.8%
4.8%
VTS
Higher net margin
VTS
VTS
89.2% more per $
VTS
-1.3%
-90.4%
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-2.1%
VTS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PACB
PACB
VTS
VTS
Revenue
$44.6M
$58.6M
Net Profit
$-40.4M
$-739.0K
Gross Margin
37.1%
Operating Margin
-92.3%
-12.0%
Net Margin
-90.4%
-1.3%
Revenue YoY
13.8%
4.8%
Net Profit YoY
-1802.7%
85.6%
EPS (diluted)
$-0.11
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PACB
PACB
VTS
VTS
Q4 25
$44.6M
$58.6M
Q3 25
$38.4M
$67.4M
Q2 25
$39.8M
$81.8M
Q1 25
$37.2M
$66.2M
Q4 24
$39.2M
$55.9M
Q3 24
$40.0M
$58.3M
Q2 24
$36.0M
$66.6M
Q1 24
$38.8M
$61.2M
Net Profit
PACB
PACB
VTS
VTS
Q4 25
$-40.4M
$-739.0K
Q3 25
$-38.0M
$-1.3M
Q2 25
$-41.9M
$24.7M
Q1 25
$-426.1M
$2.7M
Q4 24
$2.4M
$-5.1M
Q3 24
$-60.7M
$17.4M
Q2 24
$-173.3M
$10.9M
Q1 24
$-78.2M
$-2.2M
Gross Margin
PACB
PACB
VTS
VTS
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
PACB
PACB
VTS
VTS
Q4 25
-92.3%
-12.0%
Q3 25
-101.1%
0.2%
Q2 25
-112.8%
22.8%
Q1 25
-1154.5%
8.1%
Q4 24
-390.1%
3.7%
Q3 24
-160.3%
15.4%
Q2 24
-488.3%
25.2%
Q1 24
-209.6%
21.4%
Net Margin
PACB
PACB
VTS
VTS
Q4 25
-90.4%
-1.3%
Q3 25
-98.9%
-1.9%
Q2 25
-105.4%
30.2%
Q1 25
-1146.8%
4.0%
Q4 24
6.0%
-9.2%
Q3 24
-151.9%
29.9%
Q2 24
-481.3%
16.4%
Q1 24
-201.4%
-3.6%
EPS (diluted)
PACB
PACB
VTS
VTS
Q4 25
$-0.11
$-0.01
Q3 25
$-0.13
$-0.03
Q2 25
$-0.14
$0.60
Q1 25
$-1.44
$0.08
Q4 24
$-0.44
$-0.15
Q3 24
$-0.22
$0.53
Q2 24
$-0.64
$0.33
Q1 24
$-0.29
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PACB
PACB
VTS
VTS
Cash + ST InvestmentsLiquidity on hand
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.3M
$629.3M
Total Assets
$784.1M
$893.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PACB
PACB
VTS
VTS
Q4 25
$279.5M
Q3 25
$298.7M
Q2 25
$314.7M
Q1 25
$343.1M
$4.5M
Q4 24
$389.9M
$3.0M
Q3 24
$471.1M
Q2 24
$509.8M
Q1 24
$561.9M
Stockholders' Equity
PACB
PACB
VTS
VTS
Q4 25
$5.3M
$629.3M
Q3 25
$36.1M
$650.3M
Q2 25
$61.5M
$671.9M
Q1 25
$91.6M
$667.7M
Q4 24
$506.6M
$500.3M
Q3 24
$453.1M
$520.4M
Q2 24
$492.7M
$518.5M
Q1 24
$649.0M
$522.7M
Total Assets
PACB
PACB
VTS
VTS
Q4 25
$784.1M
$893.4M
Q3 25
$803.2M
$932.9M
Q2 25
$825.5M
$951.5M
Q1 25
$860.8M
$975.2M
Q4 24
$1.3B
$810.9M
Q3 24
$1.5B
$791.2M
Q2 24
$1.5B
$778.4M
Q1 24
$1.7B
$749.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PACB
PACB
VTS
VTS
Operating Cash FlowLast quarter
$-19.1M
$37.4M
Free Cash FlowOCF − Capex
$-19.9M
FCF MarginFCF / Revenue
-44.6%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PACB
PACB
VTS
VTS
Q4 25
$-19.1M
$37.4M
Q3 25
$-18.7M
$49.4M
Q2 25
$-29.4M
$66.0M
Q1 25
$-44.1M
$17.5M
Q4 24
$-30.6M
$34.7M
Q3 24
$-45.5M
$45.7M
Q2 24
$-54.3M
$35.2M
Q1 24
$-75.7M
$39.4M
Free Cash Flow
PACB
PACB
VTS
VTS
Q4 25
$-19.9M
Q3 25
$-18.8M
Q2 25
$-29.9M
Q1 25
$-45.4M
Q4 24
$-32.3M
Q3 24
$-46.3M
Q2 24
$-55.7M
Q1 24
$-79.6M
FCF Margin
PACB
PACB
VTS
VTS
Q4 25
-44.6%
Q3 25
-48.9%
Q2 25
-75.3%
Q1 25
-122.3%
Q4 24
-82.3%
Q3 24
-115.7%
Q2 24
-154.8%
Q1 24
-205.0%
Capex Intensity
PACB
PACB
VTS
VTS
Q4 25
1.9%
Q3 25
0.2%
Q2 25
1.4%
Q1 25
3.7%
Q4 24
4.1%
Q3 24
2.0%
Q2 24
4.1%
Q1 24
10.0%
Cash Conversion
PACB
PACB
VTS
VTS
Q4 25
Q3 25
Q2 25
2.68×
Q1 25
6.56×
Q4 24
-12.93×
Q3 24
2.62×
Q2 24
3.22×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

VTS
VTS

Oil Reserves$54.5M93%
Natural Gas Reserves$4.2M7%

Related Comparisons